Poxel: Details of share capital and voting rights

Poxel, a biopharmaceutical company based in Lyon, published its regulatory figures on June 6, 2025, regarding total shares and voting rights. In accordance with the articles of the French Commercial Code and the AMF General Regulations, as of May 31, 2025, the total number of shares comprising Poxel's capital is 53,758,167. Gross voting rights reach the same number, while exercisable voting rights are 53,729,966. This detailed information is available on the company's website, under the section dedicated to regulated information for shareholders. This press release underlines Poxel's transparency towards its investors.